BDBM246293 US10183932, Example 199::US9434690, 199::US9822102, Example 199

SMILES: COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F

InChI Key: InChIKey=OTYWURKUSAPCDC-YDNXMHBPSA-N

Data: 6 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 246293   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Coagulation factor XI (Homo sapiens (Human))	BDBM246293 (US10183932, Example 199 | US9434690, 199 | US98221...) Show SMILES COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F |r| Show InChI InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	7.4	25
Bayer Pharma Aktiengesellschaft US Patent					Assay Description Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000 μM to 0.0078 μM; resulting final con...				US Patent US9434690 (2016) BindingDB Entry DOI: 10.7270/Q2K936FF
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM246293 (US10183932, Example 199 | US9434690, 199 | US98221...) Show SMILES COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F |r| Show InChI InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	34	n/a	n/a	n/a	n/a	7.4	25
Bayer Pharma Aktiengesellschaft US Patent					Assay Description Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000 μM to 0.0078 μM; resulting final con...				US Patent US9434690 (2016) BindingDB Entry DOI: 10.7270/Q2K936FF
					More data for this Ligand-Target Pair
Plasma kallikrein (Homo sapiens (Human))	BDBM246293 (US10183932, Example 199 | US9434690, 199 | US98221...) Show SMILES COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F |r| Show InChI InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	34	n/a	n/a	n/a	n/a	n/a	n/a
BAYER PHARMA AKTIENGESELLSCHAFT US Patent					Assay Description Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000 μM to 0.0078 μM; resulting final con...				US Patent US9822102 (2017) BindingDB Entry DOI: 10.7270/Q2FN18G5
					More data for this Ligand-Target Pair
Coagulation factor XI (Homo sapiens (Human))	BDBM246293 (US10183932, Example 199 | US9434690, 199 | US98221...) Show SMILES COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F |r| Show InChI InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	34	n/a	n/a	n/a	n/a	n/a	n/a
Bayer Pharma Aktiengesellschaft US Patent					Assay Description To determine the factor XIa inhibition of the substances according to the invention, a biochemical test system is used which utilizes the reaction of...				US Patent US10183932 (2019) BindingDB Entry DOI: 10.7270/Q23T9K99
					More data for this Ligand-Target Pair
Coagulation factor XI (Homo sapiens (Human))	BDBM246293 (US10183932, Example 199 | US9434690, 199 | US98221...) Show SMILES COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F |r| Show InChI InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
BAYER PHARMA AKTIENGESELLSCHAFT US Patent					Assay Description Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000 μM to 0.0078 μM; resulting final con...				US Patent US9822102 (2017) BindingDB Entry DOI: 10.7270/Q2FN18G5
					More data for this Ligand-Target Pair
Coagulation factor XI (Homo sapiens (Human))	BDBM246293 (US10183932, Example 199 | US9434690, 199 | US98221...) Show SMILES COc1cn(C(C[C@@H]2CCCCO2)C(=O)Nc2ccc(cc2)C(O)=O)c(=O)cc1-c1cc(Cl)ccc1OC(F)F |r| Show InChI InChI=1S/C28H27ClF2N2O7/c1-38-24-15-33(25(34)14-21(24)20-12-17(29)7-10-23(20)40-28(30)31)22(13-19-4-2-3-11-39-19)26(35)32-18-8-5-16(6-9-18)27(36)37/h5-10,12,14-15,19,22,28H,2-4,11,13H2,1H3,(H,32,35)(H,36,37)/t19-,22?/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
Bayer Pharma Aktiengesellschaft US Patent					Assay Description To determine the factor XIa inhibition of the substances according to the invention, a biochemical test system is used which utilizes the reaction of...				US Patent US10183932 (2019) BindingDB Entry DOI: 10.7270/Q23T9K99
					More data for this Ligand-Target Pair